Form 4 · Filed Jul 16, 2026, 08:30 PM UTC
PHAT/Phathom Pharmaceuticals, Inc.
Breedlove Robert Charles — Principal Accounting Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | F | other | 1,555 | $11 | $17,159 | 59,925 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-306165